What is Semaglutide 1.7 mg FlexTouch Pen?
Semaglutide 1.7 mg FlexTouch Pen is a prescription medication developed by Novo Nordisk India, designed specifically for the management of weight loss and maintenance in adults who are overweight or obese. It comes in a convenient injectable pen format, allowing for easy and accurate self-administration.
The active ingredient, Semaglutide, is a glucagon-like peptide-1 (GLP-1) receptor agonist, which mimics a natural hormone that regulates appetite and food intake. This medication supports users by helping to reduce hunger, promoting a feeling of fullness, and assisting in calorie control, all of which contribute to effective weight management.
Approved for use in a variety of adult patients, this Semaglutide 1.7 mg FlexTouch Pen is an important option for those seeking medically-supported weight loss solutions as part of a comprehensive plan including diet and exercise. It has been clinically studied and is widely recognized for its efficacy and safety profile when used as directed.
Uses of Semaglutide 1.7 mg FlexTouch Pen
- Weight loss in overweight or obese adults
- Assisting in weight maintenance after initial weight loss
- Helping control appetite and reduce caloric intake
- Supporting healthier eating habits through enhanced satiety
How Semaglutide 1.7 mg FlexTouch Pen Works
Semaglutide works by mimicking the GLP-1 hormone that naturally occurs in the body. It activates GLP-1 receptors in the brain to regulate appetite and food consumption. This leads to delayed gastric emptying, promoting prolonged fullness and decreased hunger sensations. The result is a lower calorie intake, which supports gradual, sustainable weight loss when combined with a healthy lifestyle.
How to take Semaglutide 1.7 mg FlexTouch Pen
This medication is administered once weekly by subcutaneous injection, typically in the abdomen, thigh, or upper arm. Patients should follow the prescribed dosage schedule exactly as instructed by their healthcare provider. It is recommended to use the FlexTouch pen on the same day each week, at any time of day, with or without food. Patients should rotate injection sites to avoid discomfort.
Benefits of Semaglutide 1.7 mg FlexTouch Pen
- Supports effective and sustained weight loss
- Reduces appetite and cravings naturally
- Easy-to-use and discreet weekly injection pen
- Clinically proven and approved medication
- Can improve overall metabolic health alongside weight loss
Dosage and Administration
The usual dose is 1.7 mg once weekly, administered by subcutaneous injection. Initiation and dose adjustments should follow medical advice to minimize side effects and optimize benefits. Patients often start at a lower dose and increase gradually to 1.7 mg. Proper injection technique and adherence to recommended dosing schedules are essential for safety and effectiveness.
Who Should Use Semaglutide 1.7 mg FlexTouch Pen?
This medication is suitable for adult patients who are overweight (BMI ≥27) or obese (BMI ≥30) and require support for weight loss and maintenance. It is intended for those who have not achieved sufficient weight reduction through diet and exercise alone and who do not have contraindications to this type of treatment.
Who Should Avoid Semaglutide 1.7 mg FlexTouch Pen?
Semaglutide 1.7 mg FlexTouch Pen is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. It should be avoided by those with known hypersensitivity to semaglutide or any pen components. Pregnant or breastfeeding women, and patients with severe gastrointestinal diseases, should consult their healthcare provider before use.
Side Effects of Semaglutide 1.7 mg FlexTouch Pen
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Abdominal pain
- Indigestion
- Headache
- Dizziness
Safety Advice
- Consult your doctor before starting treatment
- Inform healthcare provider about other medications
- Report any severe or persistent side effects promptly
- Avoid usage if allergic to semaglutide or pen components
- Use exactly as prescribed; do not alter dosage without medical guidance
- Keep out of reach of children
Drug Interactions
Storage Instructions
Store the Semaglutide 1.7 mg FlexTouch Pen in a refrigerator between 2°C and 8°C (36°F and 46°F). Do not freeze the pen. Keep it protected from light. Once in use, the pen can be kept at room temperature not exceeding 30°C for up to 30 days. Always check the expiration date before use.
Where to buy Semaglutide 1.7 mg FlexTouch Pen in Malaysia?
In Malaysia, Semaglutide 1.7 mg FlexTouch Pen can be purchased through licensed pharmacies and authorized online medical suppliers. It is important to buy from reputable sources to ensure product authenticity and safety. A valid prescription from a healthcare provider is required to obtain this medication legally.
Frequently Asked Questions (FAQ)
What is the price of Semaglutide 1.7 mg FlexTouch Pen in Malaysia?
Prices vary depending on the pharmacy and insurance coverage; consult local pharmacies for the most accurate pricing.
What happens if I miss a dose?
If you miss your scheduled dose, take it as soon as possible within 5 days. If more than 5 days have passed, skip the missed dose and continue with your next scheduled dose.
Where can I find Semaglutide 1.7 mg FlexTouch Pen for sale?
This medication is available at licensed pharmacies and authorized online medical retailers in Malaysia with a valid prescription.
Is Semaglutide 1.7 mg FlexTouch Pen available in Malaysia?
Yes, it is available in Malaysia through authorized distributors and pharmacies.
Can Semaglutide 1.7 mg FlexTouch Pen be used for managing diabetes?
While Semaglutide has indications for diabetes, the 1.7 mg dose in FlexTouch pen is specifically formulated for weight loss in overweight or obese adults.
Are there any dietary restrictions while using Semaglutide 1.7 mg FlexTouch Pen?
There are no strict dietary restrictions, but following a healthy, balanced diet enhances the effectiveness of the medication.
How long does it take to see results with Semaglutide 1.7 mg FlexTouch Pen?
Weight loss results generally become noticeable within a few weeks, with continued improvements over several months when combined with lifestyle changes.
Conclusion
Semaglutide 1.7 mg FlexTouch Pen is a medically advanced and convenient treatment option for overweight and obese adults seeking support in weight loss and maintenance. Manufactured by Novo Nordisk India, this medication offers clinically proven benefits by controlling appetite and supporting healthier eating habits. Proper usage under medical supervision can significantly aid in achieving sustainable weight management goals.
Leave A Review